Market Overview

Benzinga's Top Upgrades, Downgrades For October 30, 2017

Share:

Top Upgrades

  • BMO Capital upgraded Intel Corporation (NASDAQ: INTC) from Market Perform to Outperform. Intel shares rose 0.23 percent to $44.50 in pre-market trading.
  • Citigroup upgraded Praxair, Inc. (NYSE: PX) from Neutral to Buy. Praxair shares dropped 1.04 percent to close at $148.14 on Friday.
  • Stifel Nicolaus upgraded Conagra Brands Inc (NYSE: CAG) from Hold to Buy. Conagra shares rose 0.12 percent to $33.73 in pre-market trading.
  • Capital One Financial upgraded Ventas, Inc. (NYSE: VTR) from Equal-Weight to Overweight. Ventas shares rose 2.29 percent to close at $62.50 on Friday.
  • Keefe Bruyette & Woods upgraded Piper Jaffray Companies (NYSE: PJC) from Market Perform to Outperform. Piper Jaffray shares gained 1.69 percent to close at $66.30 on Friday.
  • Analysts at Bank of America upgraded Curtiss-Wright Corp. (NYSE: CW) from Neutral to Buy. Curtiss-Wright shares gained 0.83 percent to close at $115.96 on Friday.
  • Analysts at DA Davidson upgraded JAKKS Pacific, Inc. (NASDAQ: JAKK) from Underperform to Neutral. JAKKS Pacific shares dropped 4.07 percent to close at $2.95 on Friday.
  • SunTrust Robinson Humphrey upgraded Bristol-Myers Squibb Co (NYSE: BMY) from Hold to Buy. Bristol-Myers shares rose 2.12 percent to $61.21 in pre-market trading.


Top Downgrades

  • Goldman Sachs downgraded General Motors Company (NYSE: GM) from Neutral to Sell. GM shares declined 3.45 percent to $43.10 in pre-market trading.
  • Citigroup downgraded Macy's Inc (NYSE: M) from Neutral to Sell. Macy's shares dropped 2.13 percent to $19.27 in pre-market trading.
  • Analysts at Susquehanna downgraded J C Penney Company Inc (NYSE: JCP) from Positive to Neutral. JC Penney shares fell 1.28 percent to $3.08 in pre-market trading.
  • Morgan Stanley downgraded Advanced Micro Devices, Inc. (NASDAQ: AMD) from Equal-Weight to Underweight. AMD shares fell 3.46 percent to $11.43 in pre-market trading.
  • Mizuho downgraded Acadia Healthcare Company Inc (NASDAQ: ACHC) from Buy to Neutral. Acadia Healthcare shares fell 5.26 percent to $31.50 in pre-market trading.
  • Canaccord Genuity downgraded Pacira Pharmaceuticals Inc (NASDAQ: PCRX) from Buy to Hold. Pacira Pharmaceuticals shares rose 2 percent to close at $33.20 on Friday.
  • Analysts at SunTrust Robinson Humphrey downgraded Merck & Co., Inc. (NYSE: MRK) from Buy to Hold. Merck shares fell 4.48 percent to $55.63 in pre-market trading.
  • Benchmark downgraded Diodes Incorporated (NASDAQ: DIOD) from Buy to Hold. Diodes shares rose 0.60 percent to close at $35.03 on Friday.
  • JP Morgan downgraded Century Aluminum Co (NASDAQ: CENX) from Overweight to Neutral. Century Aluminum shares fell 0.26 percent to close at $15.18 on Thursday.
  • Bank of America downgraded Under Armour Inc (NYSE: UAA) from Neutral to Underperform. Under Armour shares fell 3.3 percent to $15.51 in pre-market trading.


Top Initiations

  • FBR Capital initiated coverage on Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) with a Buy rating. The price target for Alnylam Pharmaceuticals is set to $150. Alnylam Pharmaceuticals shares closed at $119.92 on Friday.
  • Bank of America initiated coverage on Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) with a Buy rating. The price target for Rhythm Pharmaceuticals is set to $30. Rhythm Pharmaceuticals shares closed at $23.72 on Friday.
  • BMO Capital initiated coverage on Calyxt Inc (NASDAQ: CLXT) with an Outperform rating. The price target for Calyxt is set to $32. Calyxt shares closed at $22.47 on Friday.
  • Analysts at Cowen & Co. initiated coverage on GCP Applied Technologies Inc (NYSE: GCP) with a Market Perform rating. The price target for GCP Applied Technologies is set to $31. GCP Applied Technologies shares closed at $29.35 on Friday.
  • Analysts at Morgan Stanley initiated coverage of Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) with an Equal-Weight rating. The price target for Rhythm Pharmaceuticals is set to $23. Rhythm Pharmaceuticals shares closed at $23.72 on Friday.
  • Analysts at Evercore ISI initiated coverage on Adamas Pharmaceuticals Inc (NASDAQ: ADMS) with an Outperform rating. The price target for Adamas Pharmaceuticals is set to $85. Adamas Pharmaceuticals shares closed at $19.51 on Friday.
  • Analysts at Barclays initiated coverage on TD Ameritrade Holding Corp. (NASDAQ: AMTD) with an Equal-Weight rating. The price target for TD Ameritrade is set to $54. TD Ameritrade shares closed at $50.51 on Friday.
  • UBS initiated coverage on Vipshop Holdings Ltd - ADR (NYSE: VIPS) with a Neutral rating. The price target for Vipshop is set to $9. Vipshop shares closed at $8.20 on Friday.

Posted-In: Upgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

 

Related Articles (ACHC + ADMS)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
YETIJefferiesMaintains40.0
DRIBank of AmericaReiterates130.0
PVACNorthland SecuritiesUpgrades0.0
NKEWells FargoMaintains80.0
DRIWells FargoMaintains120.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Trader Essentials
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Benzinga's Bulls And Bears Of The Past Week: Apple, Caterpillar, Tesla And More

Goldman Downgrades GM On Absolute Downside In 2018